Annual CFO
-$214.23 M
-$26.03 M-13.83%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual cash flow from operations is -$214.23 million, with the most recent change of -$26.03 million (-13.83%) on March 31, 2024.
- During the last 3 years, IMVT annual CFO has fallen by -$130.90 million (-157.09%).
- IMVT annual CFO is now -301.50% below its all-time high of -$53.36 million, reached on March 31, 2020.
Performance
IMVT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$100.39 M
-$11.74 M-13.25%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly cash flow from operations is -$100.39 million, with the most recent change of -$11.74 million (-13.25%) on December 31, 2024.
- Over the past year, IMVT quarterly CFO has dropped by -$53.29 million (-113.15%).
- IMVT quarterly CFO is now -25097650.00% below its all-time high of -$400.00, reached on March 31, 2019.
Performance
IMVT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$324.94 M
-$53.29 M-19.62%
December 31, 2024
Summary
- As of February 12, 2025, IMVT TTM cash flow from operations is -$324.94 million, with the most recent change of -$53.29 million (-19.62%) on December 31, 2024.
- Over the past year, IMVT TTM CFO has dropped by -$114.61 million (-54.50%).
- IMVT TTM CFO is now -81233900.00% below its all-time high of -$400.00, reached on March 31, 2019.
Performance
IMVT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IMVT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.8% | -113.2% | -54.5% |
| 3 y3 years | -157.1% | -214.8% | -239.7% |
| 5 y5 years | -301.5% | - | - |
IMVT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -157.1% | at low | -397.3% | at low | -239.7% | at low |
| 5 y | 5-year | -301.5% | at low | -627.6% | at low | -2204.6% | at low |
| alltime | all time | -301.5% | at low | <-9999.0% | at low | <-9999.0% | at low |
Immunovant Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$100.39 M(+13.2%) | -$324.94 M(+19.6%) |
| Sep 2024 | - | -$88.65 M(+16.3%) | -$271.64 M(+11.8%) |
| Jun 2024 | - | -$76.20 M(+27.6%) | -$243.06 M(+13.5%) |
| Mar 2024 | -$214.23 M(+13.8%) | -$59.70 M(+26.8%) | -$214.23 M(+1.9%) |
| Dec 2023 | - | -$47.10 M(-21.6%) | -$210.32 M(+0.3%) |
| Sep 2023 | - | -$60.06 M(+26.8%) | -$209.62 M(+23.5%) |
| Jun 2023 | - | -$47.37 M(-15.1%) | -$169.74 M(-9.8%) |
| Mar 2023 | -$188.19 M(+77.4%) | -$55.79 M(+20.3%) | -$188.19 M(+13.8%) |
| Dec 2022 | - | -$46.40 M(+129.8%) | -$165.36 M(+9.6%) |
| Sep 2022 | - | -$20.19 M(-69.3%) | -$150.86 M(+0.1%) |
| Jun 2022 | - | -$65.82 M(+99.7%) | -$150.72 M(+42.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | -$106.11 M(+27.3%) | -$32.96 M(+3.3%) | -$106.11 M(+10.9%) |
| Dec 2021 | - | -$31.89 M(+59.1%) | -$95.65 M(+10.5%) |
| Sep 2021 | - | -$20.05 M(-5.5%) | -$86.57 M(-4.6%) |
| Jun 2021 | - | -$21.21 M(-5.7%) | -$90.74 M(+8.9%) |
| Mar 2021 | -$83.33 M(+56.2%) | -$22.50 M(-1.4%) | -$83.33 M(+37.0%) |
| Dec 2020 | - | -$22.82 M(-5.8%) | -$60.83 M(+60.0%) |
| Sep 2020 | - | -$24.22 M(+75.5%) | -$38.02 M(+169.6%) |
| Jun 2020 | - | -$13.80 M(+4476.5%) | -$14.10 M(+2549.3%) |
| Mar 2020 | -$53.36 M | - | - |
| Sep 2019 | - | -$301.50 K(+30.9%) | -$532.20 K(+130.7%) |
| Jun 2019 | - | -$230.30 K(>+9900.0%) | -$230.70 K(>+9900.0%) |
| Mar 2019 | - | -$400.00 | -$400.00 |
FAQ
- What is Immunovant annual cash flow from operations?
- What is the all time high annual CFO for Immunovant?
- What is Immunovant annual CFO year-on-year change?
- What is Immunovant quarterly cash flow from operations?
- What is the all time high quarterly CFO for Immunovant?
- What is Immunovant quarterly CFO year-on-year change?
- What is Immunovant TTM cash flow from operations?
- What is the all time high TTM CFO for Immunovant?
- What is Immunovant TTM CFO year-on-year change?
What is Immunovant annual cash flow from operations?
The current annual CFO of IMVT is -$214.23 M
What is the all time high annual CFO for Immunovant?
Immunovant all-time high annual cash flow from operations is -$53.36 M
What is Immunovant annual CFO year-on-year change?
Over the past year, IMVT annual cash flow from operations has changed by -$26.03 M (-13.83%)
What is Immunovant quarterly cash flow from operations?
The current quarterly CFO of IMVT is -$100.39 M
What is the all time high quarterly CFO for Immunovant?
Immunovant all-time high quarterly cash flow from operations is -$400.00
What is Immunovant quarterly CFO year-on-year change?
Over the past year, IMVT quarterly cash flow from operations has changed by -$53.29 M (-113.15%)
What is Immunovant TTM cash flow from operations?
The current TTM CFO of IMVT is -$324.94 M
What is the all time high TTM CFO for Immunovant?
Immunovant all-time high TTM cash flow from operations is -$400.00
What is Immunovant TTM CFO year-on-year change?
Over the past year, IMVT TTM cash flow from operations has changed by -$114.61 M (-54.50%)